SCHEMBL691255

SCHEMBL691255

CC(=O)Nc1nc2c(s1)C(O)=C(C(=O)c1ccc(N(C)C(=O)O)nc1)CCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
NPC1 O15118 2/20 0.39
TP53 P04637 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
LMNA P02545 3/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
GFER P55789 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PIK3CG P48736 7/20 0.35
PIK3CD O00329 2/20 0.35
PIK3CA P42336 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692451 0.89 NPC1 (0.37) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL1781135 0.86 PIK3CG (0.39) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL1770958 0.85 ABL1 (0.34) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL1781491 0.79 PIK3CG (0.42) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL1770081 0.79 PI4KA (0.32) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL1782049 0.78 PIK3CG (0.38) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL2671947 0.78 PI4KB (0.36) ALDH1A1LMNAGAAMAPTHPGD
SCHEMBL1783223 0.78 OGA (0.42) ALDH1A1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL13690398 0.78 PIK3CA (0.43) LMNAGAAMAPTHPGDPIK3CG
SCHEMBL1781217 0.78 PIK3CG (0.43) ALDH1A1NPC1RAB9ASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421871-A1 THIA-TRIAZA-CYCLOPENTAZULENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER Boehringer Ingelheim International GmbH (DE) 2012-02-29 EP disclosed
WO-2010122071-A1 THIA-TRIAZA-CYCLOPENTAZULENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-28 WO disclosed